SCA-12 (SPINOCEREBELLAR ATAXIA) GENE MUTATION ANALYSIS
MRP - ₹ 2,900
What is a SCA-12 (SPINOCEREBELLAR ATAXIA) GENE MUTATION ANALYSIS?
The SCA-12 (Spinocerebellar Ataxia) Gene Mutation Analysis test is a genetic diagnostic procedure used to detect mutations in the PPP2R2B gene, which are responsible for Spinocerebellar Ataxia type 12. This inherited neurodegenerative disorder affects coordination, balance, and movement, often presenting with tremors and progressive ataxia. Doctors order this test to confirm a suspected diagnosis, differentiate it from other ataxias, and provide genetic counseling for families. It plays a crucial role in early detection, prognosis, and guiding patient management.
Additional Information
| Also known as/ Other names: | Spinocerebellar Ataxia Type 12 Genetic Test, SCA‑12 Mutation Analysis, Spinocerebellar Ataxia Gene Panel – Type 12, SCA‑12 DNA Test, Spinocerebellar Ataxia Type 12 Molecular Diagnosis, SCA‑12 Genetic Screening |
| Parameters: | 1 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood |
| Patient Preparation: | No prior preparation is needed |
| Reports: | 15 Days |
FAQs
Yes, it identifies mutations passed from parent to child, confirming hereditary nature of SCA-12.
Yes, certain populations may show higher prevalence of SCA-12 mutations.
Certainly, results help predict disease progression and guide long-term care planning.
No, genetic mutations remain constant throughout life, so repeat testing is not required.
Yes, it supports personalized care by tailoring monitoring and management strategies.
Yes, counseling helps families understand inheritance, risks, and implications for future generations.
Neurological exams, MRI, and other genetic panels may be ordered alongside.